Radiation exposure during cardiac imaging is an invisible but measurable risk that most patients never think to ask about — yet the dose received can vary enormously depending on where in the world that imaging takes place. The INCAPS 4 study, published in JAMA, offers the most comprehensive global mapping to date of radiation doses delivered during coronary artery disease (CAD) diagnostic procedures, with findings that carry direct implications for patient safety across healthcare systems of vastly different resource levels.
The study documents significant international variation in radiation doses associated with cardiac imaging modalities used to evaluate coronary artery disease. This kind of cross-national benchmarking is methodologically valuable because it exposes gaps between best-practice dose optimization and real-world clinical implementation — gaps that are not evenly distributed across high- and low-income settings. The INCAPS 4 data effectively creates a global baseline against which institutions can measure their own protocols.
For context, radiation dose optimization in cardiac imaging has been an active area of concern for over a decade. Techniques such as prospective ECG-gating, iterative reconstruction in CT, and dose-modulation software have substantially reduced exposure in centers that adopt them — yet uptake remains uneven globally. The INCAPS study series has been instrumental in making these disparities visible. The critical limitation here is that a letter-to-the-editor format, rather than original data presentation, limits full methodological scrutiny. The finding is nonetheless directionally significant: international patient safety in cardiac imaging is not solely a clinical question but an infrastructure and training question. For health-conscious adults, the practical implication is that the radiation risk associated with a cardiac CT or nuclear scan is not fixed — it is a function of where, and how, the procedure is performed.